Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
68
-
Total shares
-
23.5M
-
Shares change
-
+12M
-
Total reported value, excl. options
-
$121M
-
Value change
-
+$62.2M
-
Put/Call ratio
-
7.43
-
Number of buys
-
53
-
Number of sells
-
-16
-
Price
-
$5.15
Significant Holders of SORRENTO THERAPEUTICS INC - Common Stock (SRNE) as of Q1 2018
72 filings reported holding SRNE - SORRENTO THERAPEUTICS INC - Common Stock as of Q1 2018.
SORRENTO THERAPEUTICS INC - Common Stock (SRNE) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
.
Largest 10 shareholders include STATE STREET CORP (5.16M shares), VANGUARD GROUP INC (3.03M shares), BlackRock Inc. (2.19M shares), MILLENNIUM MANAGEMENT LLC (1.43M shares), Intellectus Partners, LLC (1.35M shares), Man Group plc (1.34M shares), DEUTSCHE BANK AG\ (938K shares), RENAISSANCE TECHNOLOGIES LLC (897K shares), D. E. Shaw & Co., Inc. (703K shares), and WELLS FARGO & COMPANY/MN (501K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.